** Shares of weight-loss services firm WW International
WW.O , also known as WeightWatchers down 6.5% to $7.2
** U.S. drugmaker Eli Lilly LLY.N launched a website that
will allow people with obesity to get prescriptions through
telehealth providers and opt for home delivery of the company's
weight-loss drug
** The service, called LillyDirect, comes on the back of the
launch of Lilly's obesity drug Zepbound last month, the latest
entrant to a market that is forecast to grow to about $100
billion by the end of the decade
** WW stock more than doubled in 2023, boosted by its
acquisition of subscription telehealth platform Sequence to
enter the obesity drug prescription business
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))